Life Spine commenced full commercial launch of the PROLIFT® Lordotic expandable interbody system with OSSEO-LOC™ surface treatment.
The system received FDA 510(k) clearance in late 1Q16. Since its limited 2Q16 launch, company leadership notes, Life Spine has “consistently doubled sales growth quarter over quarter.”
PROLIFT Lordotic supports in situ disc height restoration for minimally invasive posterior lumbar interbody fusion, transforaminal lumbar interbody fusion and oblique approaches. Its OSSEO-LOC surface treatment is designed to help recruit osteoblasts on the implant’s surface to promote healing and fusion.
Life Spine commenced full commercial launch of the PROLIFT® Lordotic expandable interbody system with OSSEO-LOC™ surface treatment.
The system received FDA 510(k) clearance in late 1Q16. Since its limited 2Q16 launch, company leadership notes, Life Spine has "consistently doubled sales growth quarter over quarter."
PROLIFT Lordotic supports...
Life Spine commenced full commercial launch of the PROLIFT® Lordotic expandable interbody system with OSSEO-LOC™ surface treatment.
The system received FDA 510(k) clearance in late 1Q16. Since its limited 2Q16 launch, company leadership notes, Life Spine has “consistently doubled sales growth quarter over quarter.”
PROLIFT Lordotic supports in situ disc height restoration for minimally invasive posterior lumbar interbody fusion, transforaminal lumbar interbody fusion and oblique approaches. Its OSSEO-LOC surface treatment is designed to help recruit osteoblasts on the implant’s surface to promote healing and fusion.
Copy to clipboard 
